LIFESCIENCELEADER.COM JUNE 2014
25
You have seen the headlines, reading like obituaries for the
about-to-be departed. You know the drill: repeated failures
in Phase 3, nothing to replace the big earners with vanishing
patents, mental images of a ship lost at sea. So why is Eli Lilly
& Company still here — sailing the same course, undiverted,
undiluted, and seemingly undeterred as the uniquely
independent Midwestern-based company it has always been?
Right now Lilly is navigating through the most instructive
and interesting period a company can traverse, and it appears
to be showing remarkable patience and perseverance against
a headwind of skepticism from the industry's Monday-morning
quarterbacks. There could be no better time than right now
to explore its strategic thinking from the viewpoint of the
company's chairman, president, and CEO, John Lechleiter.
INNOVATI N
LILLY NAVIGATES
THE REALITIES OF
W A Y N E K O B E R S T E I N Executive Editor
F e a t u r e - C o v e r - L i l l y . i n d d 2 Feature-Cover-Lilly.indd 2 5 / 2 1 / 2 0 1 4 1 2 : 1 5 : 4 8 P M 5/21/2014 12:15:48 PM